Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02454270
Title A Dose Escalation Study of JNJ-64052781 in Participants With Relapsed or Refractory B-cell Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

diffuse large B-cell lymphoma

follicular lymphoma

acute lymphoblastic leukemia

chronic lymphocytic leukemia

mantle cell lymphoma

Therapies

JNJ-64052781

Age Groups: adult
Covered Countries USA


No variant requirements are available.